Pdt Partners, LLC Athenex, Inc. Transaction History

Pdt Partners, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$4.08 - $14.75 $101,898 - $368,381	-24,975 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$11.06 - $14.01 $111,495 - $141,234	10,081 Added 67.68%	24,975 $276,000
Q3 2020 Nov 16, 2020	BUY	$10.26 - $14.55 $152,812 - $216,707	14,894 New	14,894 $180,000
Q2 2020 Aug 14, 2020	SELL	$7.11 - $13.76 $234,224 - $453,295	-32,943 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$5.71 - $15.85 $65,739 - $182,481	11,513 Added 53.72%	32,943 $255,000

Q4 2019 Feb 14, 2020	BUY	$9.6 - $17.75 $205,728 - $380,382	21,430 New	21,430 $327,000

1.46M

Ticker ATNX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 156,790,000
Market Cap $1.57M
Description
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Pdt Partners, LLC with notifications on news.